sry retatrutide Retatrutide FDA Approval Status: August

GLP-1s cause weight loss which has inherent health benefits, but the exact mechanism of GLP-1s for these other indications is not fully known

the 2025 JAMA Network Open cohort (HR 0.63 incident dementia in T2DM & obesity), the VA ~200,000 patient cohort and the 1.7-million-patient target-trial emulation

Beginners to resistance training may achieve modest body recomposition on semaglutide with creatine

Your telehealth appointment is a real-time video visit with a licensed clinician, a face-to-face conversation, not a form

The CAROLINA trial is the first active comparator CVOT in the DPP4i class and compared linagliptin to glimepiride on cardiovascular safety and non-inferiority with subsequent hierarchical testing for superiority among adults with T2DM and established CVD (34.5%) or increased cardiovascular risk factors alone, with a median follow-up of more than 6 yearsthe longest follow-up of any DPP4i studied to date